You just read:

Navidea Pharmaceuticals Inc. Analyst Report: Long Term Market Potential of Lymphoseek does not Justify Current Valuation by BrokerBank Securities, Inc.

News provided by

BrokerBank Securities, Inc.

Apr 11, 2014, 07:00 ET